Profile for South Korea Patent: 20050018952
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for South Korea Patent: 20050018952
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Jan 4, 2024 | Novartis | TASIGNA | nilotinib hydrochloride |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |